These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17086209)

  • 41. An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer.
    Mamo A; Cavallone L; Tuzmen S; Chabot C; Ferrario C; Hassan S; Edgren H; Kallioniemi O; Aleynikova O; Przybytkowski E; Malcolm K; Mousses S; Tonin PN; Basik M
    Oncogene; 2012 Apr; 31(16):2090-100. PubMed ID: 21892209
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An inactivating mutation in HDAC2 leads to dysregulation of apoptosis mediated by APAF1.
    Hanigan CL; Van Engeland M; De Bruine AP; Wouters KA; Weijenberg MP; Eshleman JR; Herman JG
    Gastroenterology; 2008 Nov; 135(5):1654-1664.e2. PubMed ID: 18834886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonsense-mediated RNA decay: a molecular system micromanaging individual gene activities and suppressing genomic noise.
    Alonso CR
    Bioessays; 2005 May; 27(5):463-6. PubMed ID: 15832387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suppression of galactosylceramidase (GALC) expression in the twitcher mouse model of globoid cell leukodystrophy (GLD) is caused by nonsense-mediated mRNA decay (NMD).
    Lee WC; Tsoi YK; Dickey CA; Delucia MW; Dickson DW; Eckman CB
    Neurobiol Dis; 2006 Aug; 23(2):273-80. PubMed ID: 16759875
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inactivation of NMD increases viability of sup45 nonsense mutants in Saccharomyces cerevisiae.
    Chabelskaya S; Gryzina V; Moskalenko S; Le Goff C; Zhouravleva G
    BMC Mol Biol; 2007 Aug; 8():71. PubMed ID: 17705828
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nonsense-mediated mRNA decay.
    Wen J; Brogna S
    Biochem Soc Trans; 2008 Jun; 36(Pt 3):514-6. PubMed ID: 18481993
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Iterative microarray and RNA interference-based interrogation of the SRC-induced invasive phenotype.
    Irby RB; Malek RL; Bloom G; Tsai J; Letwin N; Frank BC; Verratti K; Yeatman TJ; Lee NH
    Cancer Res; 2005 Mar; 65(5):1814-21. PubMed ID: 15753379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel function for alternative polyadenylation as a rescue pathway from NMD surveillance.
    Gilat R; Shweiki D
    Biochem Biophys Res Commun; 2007 Feb; 353(2):487-92. PubMed ID: 17188645
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence that the nonsense-mediated mRNA decay pathway participates in X chromosome dosage compensation in mammals.
    Yin S; Deng W; Zheng H; Zhang Z; Hu L; Kong X
    Biochem Biophys Res Commun; 2009 Jun; 383(3):378-82. PubMed ID: 19364502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The putative tumor suppressor AIM2 is frequently affected by different genetic alterations in microsatellite unstable colon cancers.
    Woerner SM; Kloor M; Schwitalle Y; Youmans H; Doeberitz Mv; Gebert J; Dihlmann S
    Genes Chromosomes Cancer; 2007 Dec; 46(12):1080-9. PubMed ID: 17726700
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nonsense-mediated decay breaks the circle?
    Graham SV
    Biochem J; 2003 Aug; 373(Pt 3):e5-6. PubMed ID: 12939168
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of frequently mutated genes with relevance to nonsense mediated mRNA decay in the high microsatellite instability cancers.
    Shin N; You KT; Lee H; Kim WK; Song M; Choi HJ; Rhee H; Nam SW; Kim H
    Int J Cancer; 2011 Jun; 128(12):2872-80. PubMed ID: 20824714
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of inactivating mutations in the JAK1, SYNJ2, and CLPTM1 genes in prostate cancer cells using inhibition of nonsense-mediated decay and microarray analysis.
    Rossi MR; Hawthorn L; Platt J; Burkhardt T; Cowell JK; Ionov Y
    Cancer Genet Cytogenet; 2005 Sep; 161(2):97-103. PubMed ID: 16102578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel therapeutic approach for genetic diseases by introduction of suppressor tRNA.
    Sako Y; Usuki F; Suga H
    Nucleic Acids Symp Ser (Oxf); 2006; (50):239-40. PubMed ID: 17150906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Failsafe nonsense-mediated mRNA decay does not detectably target eIF4E-bound mRNA.
    Matsuda D; Hosoda N; Kim YK; Maquat LE
    Nat Struct Mol Biol; 2007 Oct; 14(10):974-9. PubMed ID: 17873884
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RNA splicing promotes translation and RNA surveillance.
    Gudikote JP; Imam JS; Garcia RF; Wilkinson MF
    Nat Struct Mol Biol; 2005 Sep; 12(9):801-9. PubMed ID: 16116435
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nonsense-mediated mRNA decay: Target genes and functional diversification of effectors.
    Rehwinkel J; Raes J; Izaurralde E
    Trends Biochem Sci; 2006 Nov; 31(11):639-46. PubMed ID: 17010613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RNA regulation and cancer development.
    Scholzová E; Malík R; Sevcík J; Kleibl Z
    Cancer Lett; 2007 Feb; 246(1-2):12-23. PubMed ID: 16675105
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Par-3 partitioning defective 3 homolog (C. elegans) and androgen-induced prostate proliferative shutoff associated protein genes are mutationally inactivated in prostate cancer cells.
    Kunnev D; Ivanov I; Ionov Y
    BMC Cancer; 2009 Sep; 9():318. PubMed ID: 19737411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of nonsense-mediated mRNA decay (NMD) by a new chemical molecule reveals the dynamic of NMD factors in P-bodies.
    Durand S; Cougot N; Mahuteau-Betzer F; Nguyen CH; Grierson DS; Bertrand E; Tazi J; Lejeune F
    J Cell Biol; 2007 Sep; 178(7):1145-60. PubMed ID: 17893241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.